Sales | About us | Legal

 

News reports | Global | Africa | Asia | Central and South America | Europe | North America | Oceania | News archive | Features | Links

HIV/AIDS treatments to help the developing world:

Price rises and delays still hamper efforts, claims report

A recent report from Medecins Sans Frontieres [MSF] shows a price rise of up to 500 per cent for less toxic first–line regimen drugs to treat HIV/AIDS in the developing world. This, together with the significant delays between when newer treatments become available in rich countries, and when they become available in the developing world, continue to hamper worldwide efforts to combat the epidemic.

The report, Untangling the Web of Price Reductions, was released at the International AIDS Society Conference in Sydney.

The conference in Sydney featured presentations on several promising new HIV/AIDS drugs which MSF says should be available in Africa, Asia and Latin America, at the same time as they are marketed in rich countries. The MSF report concludes that the needs of people in developing countries should be included into the research and development plans from the very start.

For further information visit the MSF website at: www.msf.org.

BACK TO GLOBAL NEWS ARCHIVE 2008

Handy guide to wellbeing series | One-worldmentalhealth.org

One-worldhealthblog | Communicatormentalhealth.org online and magazine UKhealthblog | EUhealthnews.eu [service starts soon] | EUhealthblog

News reports in a language of your choice | Free translation services online


Mind+body wellbeing | Government policy | Economics | Work and training | Education | Age | Families | Caregiving | Nutrition | Exercise | Housing |
Poverty | Abuse | Human rights | Prisons | War | Transport